Medical Policy and Coding Updates - April 2025
Summary
Physical and occupational therapy services for individual plans require prior authorization starting with the seventh visit, effective July 3, 2025. Humira (adalimumab) with NDCs starting with 00074 changed from a preferred to a non-preferred adalimumab product, effective July 1, 2025. Several codes now require medical necessity review or prior authorization, and Carelon genetic testing uses the sample or collection date as the date of service for dates of service on and after August 1, 2025.
Get alerts when payers change rules like this one
We check Premera Blue Cross and other payers every day and email you when a change matches your specialty and state.